US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
Release time：2024-05-22 09:48:01 Source：Global Grid news portal
WASHINGTON (AP) — Federal regulators are challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic, in the latest action by the Biden administration targeting industry practices that drive up pharmaceutical prices.
The Federal Trade Commission on Tuesday sent warning letters to 10 drugmakers, taking issue with patents on popular drugs for weight loss, diabetes, asthma and other reparatory conditions. The letters allege that certain patents filed by Novo Nordisk, GlaxoSmithKline, AstraZeneca and seven other companies are inaccurate or misleading.
Brand-name drugmakers use patents to protect their medicines and stave off cheaper, generic medicines. Most blockbuster drugs are protected by dozens of patents covering various ingredients, manufacturing processes and intellectual property. Generic drugmakers can only launch their own cheaper versions if the patents have expired or are successfully challenged in court.
- Previous：Tigers starter Olson leaves game against Royals after being struck by line drive
- Next：'IF' movie review: John Krasinski’s film hits a box office nerve with $35 million debut
Related articles
- Russian general who criticized equipment shortages in Ukraine is arrested on bribery charges
- Coalition government falling short on mosque attack anniversary
- Oscars 2024: Barbie's Greta Gerwig and Margot Robbie miss key nominations
- 'Penalty on a plug'
- Elvis' granddaughter Riley Keough fights Graceland estate auction
- Government 'looking at' mining on DOC lands
- Upgrades badly needed for PM's residence
- Labour defends roadside drug testing legislation
- Rafael Devers sets team record by homering in 6th straight game as Red Sox top Rays 5
- Israeli military says 24 soldiers killed in Gaza fighting
- US Open champ Coco Gauff urges young Americans to vote
- Port of Auckland workers protest mayor's long
- Call for schools soft drink ban renewed after government implements cellphone ban
- Japan unexpectedly slips into a recession
- Juneteenth proclaimed state holiday again in Alabama, after bill to make it permanent falters
- Coalition government falling short on mosque attack anniversary
- Port of Auckland workers protest mayor's long
- School truancy will leave 80
- Congo names third American in a foiled coup plot as mourners gather in Utah to remember plot leader
- Pair charged with hijacking car in Auckland
Random recommendation
- Copyright © 2024 Powered by US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition ,Global Grid news portal sitemap